Related Experiment Video
Updated: May 22, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Update on the management of hypertension for secondary stroke prevention
Luis Castilla-Guerra1, María Del Carmen Fernández-Moreno
1Department of Internal Medicine, Hospital de la Merced, Osuna, Spain. castillafernandez @ hotmail.com
Insights
High blood pressure (hypertension) significantly increases stroke risk. Managing blood pressure after a stroke is crucial for preventing recurrent events, though optimal strategies are still being refined.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Public Health
Background:
- High blood pressure (hypertension) is the leading risk factor for stroke, contributing to nearly 50% of all stroke cases.
- Both diastolic and isolated systolic hypertension are significant predictors of both primary and recurrent strokes.
- While primary stroke prevention through hypertension management is established, post-stroke blood pressure lowering remains uncertain due to potential risks like impaired cerebral perfusion.
Purpose of the Study:
- To review the most recent evidence on managing hypertension in patients who have experienced a stroke.
- To address the uncertainties surrounding post-stroke blood pressure management and antihypertensive therapy for recurrent stroke prevention.
- To incorporate recent guideline updates from the American Heart Association and American Stroke Association regarding blood pressure management in stroke patients.
Main Methods:
- Systematic review of recent clinical trials and evidence.
- Analysis of data concerning the efficacy and safety of antihypertensive therapies in stroke survivors.
- Evaluation of current guidelines and unresolved questions in post-stroke blood pressure management.
Main Results:
- Evidence supports blood pressure lowering for first stroke prevention, but trials focusing on recurrent stroke prevention are limited.
- Blood pressure management in stroke patients is complex, with ongoing debates on drug choice and reduction targets.
- Recent guidelines offer new recommendations for blood pressure management in recurrent stroke prevention.
Conclusions:
- Effective management of hypertension is critical for reducing stroke incidence and recurrence.
- Further research is needed to clarify optimal blood pressure targets and therapeutic strategies for stroke survivors.
- Adherence to updated guidelines is essential for improving outcomes in patients with a history of stroke.
Abstract:
High blood pressure (BP) is the strongest risk factor for stroke. It is estimated that almost 50% of strokes may be attributable to hypertension. Both diastolic and isolated systolic hypertension are important predictors of primary or recurrent strokes, and even minor decreases in BP can reduce the risk of stroke. While the primary prevention of stroke through the treatment of hypertension is well established, the issue of lowering BP after a stroke has been uncertain, particularly since this might worsen cerebral perfusion if autoregulation remains chronically damaged or severe carotid artery stenosis is present. Furthermore, there is substantial evidence to support BP lowering for prevention of a first stroke; however, few trials have focused on antihypertensive therapy for recurrent stroke prevention. In fact, currently, BP management in patients with strokes remains problematic, and questions such as the choice of antihypertensive drug and by how much to reduce BP are yet to be resolved. Recently, the American Heart Association and American Stroke Association published updated guidelines for recurrent stroke prevention, and new recommendations on BP management have been included. Our review presents the most recent evidence on the management of hypertension in patients who have had a stroke.
Related Concept Videos
Hypertension V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology